Report #2891730

Received Apr 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: PA
Recovered: Unknown
Vaccinated: Mar 26, 2026
Onset: Mar 26, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAP	DTAP (INFANRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	5ST5M	LL

Symptoms (2)

Expired product administeredProduct administered to patient of inappropriate age

Symptom narrative

Inappropriate age at vaccine administration; Expired vaccine used; This non-serious case was reported by a nurse via sales rep and described the occurrence of inappropriate age at vaccine administration in a child female patient who received DTPa (Infanrix) (batch number 5ST5M, expiry date 24-MAR-2026) for prophylaxis. On 26-MAR-2026, the patient received the 1st dose of Infanrix (left thigh). On 26-MAR-2026, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration) and expired vaccine used (Verbatim: Expired vaccine used). The outcome of the inappropriate age at vaccine administration and expired vaccine used were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 26-MAR-2026 The reporter consented to follow up.